KROS · Company research
Keros Therapeutics, Inc. Common Stock (KROS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 11.21 | $223,347,632.16 | -34258367.84 | 6.8393411926234248 | — | — | 608.5766543869209809 | 0.85143196157365050320 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.